trulieve cannabis corp - TCNNF

TCNNF

Close Chg Chg %
6.09 0.03 0.49%

Open Market

6.12

+0.03 (0.49%)

Volume: 90.48K

Last Updated:

Mar 26, 2026, 1:39 PM EDT

Company Overview: trulieve cannabis corp - TCNNF

TCNNF Key Data

Open

$6.03

Day Range

5.99 - 6.13

52 Week Range

3.02 - 11.83

Market Cap

$1.17B

Shares Outstanding

192.31M

Public Float

161.89M

Beta

1.13

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.61

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

183.90K

 

TCNNF Performance

1 Week
 
-1.62%
 
1 Month
 
-4.69%
 
3 Months
 
-22.81%
 
1 Year
 
57.32%
 
5 Years
 
-87.39%
 

TCNNF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔

About trulieve cannabis corp - TCNNF

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

TCNNF At a Glance

Trulieve Cannabis Corp.
3494 Martin Hurst Road
Tallahassee, Florida 32312
Phone 1-850-298-8866 Revenue 1.18B
Industry Agricultural Commodities/Milling Net Income -116,381,000.00
Sector Process Industries Employees 5,000
Fiscal Year-end 12 / 2026
View SEC Filings

TCNNF Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.407
Price to Book Ratio 1.439
Price to Cash Flow Ratio 6.09
Enterprise Value to EBITDA 5.877
Enterprise Value to Sales 1.653
Total Debt to Enterprise Value 0.289

TCNNF Efficiency

Revenue/Employee 236,236.00
Income Per Employee -23,276.20
Receivables Turnover 58.474
Total Asset Turnover 0.416

TCNNF Liquidity

Current Ratio 4.433
Quick Ratio 2.524
Cash Ratio 2.013

TCNNF Profitability

Gross Margin 50.249
Operating Margin 13.443
Pretax Margin 7.744
Net Margin -9.853
Return on Assets -3.897
Return on Equity -9.145
Return on Total Capital -6.422
Return on Invested Capital -5.902

TCNNF Capital Structure

Total Debt to Total Equity 48.537
Total Debt to Total Capital 32.677
Total Debt to Total Assets 20.468
Long-Term Debt to Equity 45.933
Long-Term Debt to Total Capital 30.923
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Trulieve Cannabis Corp - TCNNF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.24B 1.13B 1.19B 1.18B
Sales Growth
+32.12% -8.92% +5.07% -0.45%
Cost of Goods Sold (COGS) incl D&A
677.19M 650.39M 583.55M 587.65M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
185.57M 166.85M 177.89M 173.40M
Depreciation
87.65M 86.45M 95.66M 90.14M
Amortization of Intangibles
97.92M 80.40M 82.23M 83.26M
COGS Growth
+61.10% -3.96% -10.28% +0.70%
Gross Income
562.62M 478.80M 602.94M 593.53M
Gross Income Growth
+8.61% -14.90% +25.93% -1.56%
Gross Profit Margin
+45.38% +42.40% +50.82% +50.25%
2022 2023 2024 2025 5-year trend
SG&A Expense
454.67M 386.16M 517.65M 434.75M
Research & Development
- - - -
-
Other SG&A
454.67M 386.16M 517.65M 434.75M
SGA Growth
+44.01% -15.07% +34.05% -16.02%
Other Operating Expense
- - - -
-
Unusual Expense
72.90M 304.37M (5.29M) 19.72M
EBIT after Unusual Expense
35.05M (211.72M) 90.58M 139.07M
Non Operating Income/Expense
1.38M 8.76M 14.33M 15.85M
Non-Operating Interest Income
1.30M 6.16M 14.68M 14.52M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
79.77M 81.57M 62.19M 63.45M
Interest Expense Growth
+129.31% +2.25% -23.75% +2.03%
Gross Interest Expense
84.47M 81.72M 63.27M 63.92M
Interest Capitalized
4.70M 148.00K 1.08M 470.00K
Pretax Income
(43.35M) (284.54M) 42.71M 91.47M
Pretax Income Growth
-126.51% -556.45% +115.01% +114.15%
Pretax Margin
-3.50% -25.20% +3.60% +7.74%
Income Tax
161.82M 151.36M 197.59M 208.11M
Income Tax - Current - Domestic
228.68M 171.49M 207.96M 225.96M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(18.35M) (18.94M) (10.37M) (17.85M)
Income Tax - Deferred - Foreign
- - (48.51M) (1.19M)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(205.17M) (435.90M) (154.88M) (116.64M)
Minority Interest Expense
(6.66M) (5.15M) (5.47M) (5.87M)
Net Income
(198.50M) (430.75M) (149.40M) (110.77M)
Net Income Growth
-1,200.83% -117.00% +65.32% +25.86%
Net Margin Growth
-16.01% -38.15% -12.59% -9.38%
Extraordinaries & Discontinued Operations
(47.56M) (96.05M) (5.70M) (5.61M)
Discontinued Operations
(47.56M) (96.05M) (5.70M) (5.61M)
Net Income After Extraordinaries
(246.06M) (526.80M) (155.11M) (116.38M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(246.06M) (526.80M) (155.11M) (116.38M)
EPS (Basic)
-1.3089 -2.7877 -0.8164 -0.6083
EPS (Basic) Growth
-1,111.51% -112.98% +70.71% +25.49%
Basic Shares Outstanding
188.00M 188.97M 189.99M 191.32M
EPS (Diluted)
-1.3089 -2.7877 -0.8164 -0.6083
EPS (Diluted) Growth
-1,165.01% -112.98% +70.71% +25.49%
Diluted Shares Outstanding
188.00M 188.97M 189.99M 191.32M
EBITDA
293.52M 259.49M 263.18M 332.19M
EBITDA Growth
+4.63% -11.59% +1.42% +26.22%
EBITDA Margin
+23.67% +22.98% +22.18% +28.12%

Snapshot

Average Recommendation BUY Average Target Price 16.258
Number of Ratings 7 Current Quarters Estimate -0.053
FY Report Date 03 / 2026 Current Year's Estimate -0.172
Last Quarter’s Earnings -0.22 Median PE on CY Estimate N/A
Year Ago Earnings -0.61 Next Fiscal Year Estimate -0.074
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 6 5
Mean Estimate -0.05 -0.04 -0.17 -0.07
High Estimates -0.02 0.00 -0.02 0.02
Low Estimate -0.11 -0.11 -0.46 -0.24
Coefficient of Variance -76.78 -117.45 -89.67 -136.35

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 7 8
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Trulieve Cannabis Corp in the News